Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Tim-3/Galectin-9 Interaction and Glutamine Metabolism in Aml Cell Lines, Hl-60 and Thp-1 Publisher Pubmed

Summary: Research suggests TIM-3/Gal-9 boosts glutamine use in leukemia cells, potentially worsening AML progression. #CancerResearch #Leukemia

Shapourian H1 ; Ghanadian M2 ; Eskandari N1 ; Shokouhi A3 ; Demirel GY4 ; Bazhin AV5, 6 ; Ganjalikhanihakemi M1, 7
Authors

Source: BMC Cancer Published:2024


Abstract

Background: T cell immunoglobulin and mucin-domain containing-3 (TIM-3) is a cell surface molecule that was first discovered on T cells. However, recent studies revealed that it is also highly expressed in acute myeloid leukemia (AML) cells and it is related to AML progression. As, Glutamine appears to play a prominent role in malignant tumor progression, especially in their myeloid group, therefore, in this study we aimed to evaluate the relation between TIM-3/Galectin-9 axis and glutamine metabolism in two types of AML cell lines, HL-60 and THP-1. Methods: Cell lines were cultured in RPMI 1640 which supplemented with 10% FBS and 1% antibiotics. 24, 48, and 72 h after addition of recombinant Galectin-9 (Gal-9), RT-qPCR analysis, RP-HPLC and gas chromatography techniques were performed to evaluate the expression of glutaminase (GLS), glutamate dehydrogenase (GDH) enzymes, concentration of metabolites; Glutamate (Glu) and alpha-ketoglutarate (α-KG) in glutaminolysis pathway, respectively. Western blotting and MTT assay were used to detect expression of mammalian target of rapamycin complex (mTORC) as signaling factor, GLS protein and cell proliferation rate, respectively. Results: The most mRNA expression of GLS and GDH in HL-60 cells was seen at 72 h after Gal-9 treatment (p = 0.001, p = 0.0001) and in THP-1 cell line was observed at 24 h after Gal-9 addition (p = 0.001, p = 0.0001). The most mTORC and GLS protein expression in HL-60 and THP-1 cells was observed at 72 and 24 h after Gal-9 treatment (p = 0.0001), respectively. MTT assay revealed that Gal-9 could promote cell proliferation rate in both cell lines (p = 0.001). Glu concentration in HL-60 and α-KG concentration in both HL-60 (p = 0.03) and THP-1 (p = 0.0001) cell lines had a decreasing trend. But, Glu concentration had an increasing trend in THP-1 cell line (p = 0.0001). Conclusion: Taken together, this study suggests TIM-3/Gal-9 interaction could promote glutamine metabolism in HL-60 and THP-1 cells and resulting in AML development. © 2024, The Author(s).
Related Docs
View other Related Docs
1. Tim-3 in Leukemia; Immune Response and Beyond, Frontiers in Oncology (2021)
2. Tim-3/Gal-9 Interaction Affects Glucose and Lipid Metabolism in Acute Myeloid Leukemia Cell Lines, Frontiers in Immunology (2023)
3. The Role of Bone Marrow Microenvironment (Bmm) Cells in Acute Myeloid Leukemia (Aml) Progression: Immune Checkpoints, Metabolic Checkpoints, and Signaling Pathways, Cell Communication and Signaling (2023)
Experts (# of related papers)
View all Related Experts
Mazdak Ganjalikhani Hakemi (12)
Hossein Khanahmad (6)
Tim-3/Galectin-9 Interaction and Glutamine Metabolism in Aml Cell Lines, Hl-60 and Thp-1
Other Related Docs
4. Silencing of Tim-3 Expression by Mir-326 Affects Apoptosis and Proliferation of Human Hl-60 Leukemia Cell Line, UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi (2018)
5. The Correlation Between Flt3-Itd Mutation in Dendritic Cells With Tim-3 Expression in Acute Myeloid Leukemia, Blood Science (2021)
6. The Role of Tim-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?, Frontiers in Oncology (2020)
7. Evaluation of Silencing Effect of Mir-133A-5P Mimic on Tim-3 Expression in Aml (Hl-60) Cell Line, Indian Journal of Clinical Biochemistry (2020)
8. Study of T-Cell Immunoglobulin and Mucin Domain-3 Expression Profile in Peripheral Blood and Bone Marrow of Human Acute Lymphoblastic Leukemia Patients, Journal of Research in Medical Sciences (2020)
9. The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies, Frontiers in Oncology (2021)
10. Evaluating T-Cell Immunoglobulin Mucin-3 (Tim-3) Receptor in the Growth Inhibition of Acute Lymphoblastic Leukemia (All) Cell Lines, Journal of Isfahan Medical School (2015)
11. Evaluation of the Effect of Tim-3 Suppression by Mir-498 and Its Effect on Apoptosis and Proliferation Rate of Hl-60 Cell Line, Pathology Research and Practice (2018)
12. Galectin-9 Inhibits Cell Proliferation and Induces Apoptosis in Jurkat and Ke-37 Acute Lymphoblastic Leukemia Cell Lines Via Caspase-3 Activation, Research in Pharmaceutical Sciences (2021)
13. Glucosamine Reverses Drug Resistance in Mrp2 Overexpressing Ovarian Cancer Cells, European Journal of Pharmacology (2020)
14. Negative Regulation of Tim-3 Expression in Aml Cell Line (Hl-60) Using Mir-330-5P, British Journal of Biomedical Science (2016)
15. Sertoli Cell–Conditioned Medium Induces Differentiation of Bone Marrow–Derived Mesenchymal Stem Cells to Male Germ-Like Cells in Busulfan-Induced Azoospermic Mouse Model, Reproductive Sciences (2024)
16. Galectin-9 Induces Il-1Β Production As a Key Inflammatory Cytokine in the Acute Myeloid Leukemia Cell Line (U937), Research in Pharmaceutical Sciences (2025)
17. Stimulation of Camel Polyclonal Antibody Against Human T Cell Immunoglobulin and Mucin 3, Iranian Journal of Biotechnology (2017)
18. The Mir-125A-3P Inhibits Tim-3 Expression in Aml Cell Line Hl-60 in Vitro, Indian Journal of Hematology and Blood Transfusion (2017)
19. Producing Recombinant Hek293 T-Cells With High Expression of T-Cell Immunoglobulin and Mucin Domain-3 (Tim3) Protein, Journal of Isfahan Medical School (2015)
20. The Effects of Astaxanthin on Ampk/Autophagy Axis and Inflammation in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Trial, Gene Reports (2023)